Gopalakrishna R, Chen Z H, Gundimeda U
Department of Pharmacology and Nutrition, School of Medicine, University of Southern California, Los Angeles 90033.
Biochem Biophys Res Commun. 1992 Dec 15;189(2):950-7. doi: 10.1016/0006-291x(92)92296-a.
The cell-permeable inhibitors of type 1 and 2A protein phosphatases, okadaic acid and calyculin-A, induced a redistribution of protein kinase C (PKC) activity and immunoreactivity (40 to 60%) from cytosol to membrane in some cell types. Calyculin-A was 100-fold more potent than okadaic acid and required only 5 to 10 nM concentrations to induce this PKC translocation. The concentration of these agents required to induce the redistribution of PKC correlated with the potency of these agents to inhibit both type 1 and 2A protein phosphatases. There was a lag period of 15 to 30 min before the onset of PKC translocation, as this process might have been induced by indirect cellular events triggered by inhibitions of protein phosphatases (1 and 2A). Taken together these results suggest that although the okadaic acid class of tumor promoters and phorbol ester-related agents bind to two different cellular receptors having counteracting enzymic activities, they share a common mechanism of action, namely the induction of cytosol to membrane translocation of PKC.
1型和2A型蛋白磷酸酶的细胞渗透性抑制剂冈田酸和花萼海绵诱癌素A,在某些细胞类型中诱导蛋白激酶C(PKC)活性和免疫反应性从胞质溶胶重新分布到细胞膜(40%至60%)。花萼海绵诱癌素A的效力比冈田酸强100倍,仅需5至10 nM的浓度就能诱导这种PKC易位。诱导PKC重新分布所需的这些试剂的浓度与它们抑制1型和2A型蛋白磷酸酶的效力相关。PKC易位开始前有15至30分钟的延迟期,因为这个过程可能是由蛋白磷酸酶(1型和2A型)抑制引发的间接细胞事件所诱导的。综合这些结果表明,尽管冈田酸类肿瘤启动子和佛波酯相关试剂与具有抵消酶活性的两种不同细胞受体结合,但它们具有共同的作用机制,即诱导PKC从胞质溶胶向细胞膜易位。